Single agent talacotuzumab demonstrates limited efficacy but considerable toxicity in elderly high-risk MDS or AML patients failing hypomethylating agents.

Document type:: Letter
Author(s):: Kubasch, Anne Sophie; Schulze, Freya; Giagounidis, Aristoteles; Götze, Katharina S; Krönke, Jan; Sockel, Katja; Middeke, Jan Moritz; Chermat, Fatiha; Gloaguen, Silke; Puttrich, Martin; Weigt, Carmen; William, Doreen; Fenaux, Pierre; Schlenk, Richard F; Thiede, Christian; Stasik, Sebastian; Mies, Anna; Adès, Lionel; Oelschlägel, Uta; Platzbecker, Uwe
Title:: Single agent talacotuzumab demonstrates limited efficacy but considerable toxicity in elderly high-risk MDS or AML patients failing hypomethylating agents.
Journal title abbreviation:: Leukemia
Year:: 2020
Journal volume:: 34
Journal issue:: 4
Pages contribution:: 1182-1186
Fulltext / DOI:: doi:10.1038/s41375-019-0645-z
Pubmed ID:: http://view.ncbi.nlm.nih.gov/pubmed/31796915
Print-ISSN:: 0887-6924
TUM Institution:: 290; III. Medizinische Klinik und Poliklinik (Hämatologie / Onkologie)
BibTeX

Occurrences: